nodes	percent_of_prediction	percent_of_DWPC	metapath
Doxorubicin—ABCC6—blood plasma—Creutzfeldt-Jakob disease	0.0256	0.0336	CbGeAlD
Doxorubicin—YWHAG—blood plasma—Creutzfeldt-Jakob disease	0.0241	0.0316	CbGeAlD
Doxorubicin—RALBP1—blood plasma—Creutzfeldt-Jakob disease	0.0218	0.0285	CbGeAlD
Doxorubicin—NOS3—blood plasma—Creutzfeldt-Jakob disease	0.0214	0.0281	CbGeAlD
Doxorubicin—NOS1—brainstem—Creutzfeldt-Jakob disease	0.016	0.021	CbGeAlD
Doxorubicin—NDUFS3—brainstem—Creutzfeldt-Jakob disease	0.0157	0.0206	CbGeAlD
Doxorubicin—ABCC3—blood plasma—Creutzfeldt-Jakob disease	0.0146	0.0192	CbGeAlD
Doxorubicin—AKR1A1—lymphoid tissue—Creutzfeldt-Jakob disease	0.0145	0.019	CbGeAlD
Doxorubicin—ABCB8—central nervous system—Creutzfeldt-Jakob disease	0.0143	0.0188	CbGeAlD
Doxorubicin—YWHAG—Activation of BAD and translocation to mitochondria—YWHAZ—Creutzfeldt-Jakob disease	0.0142	0.0597	CbGpPWpGaD
Doxorubicin—ABCB8—cerebellum—Creutzfeldt-Jakob disease	0.014	0.0184	CbGeAlD
Doxorubicin—CBR3—central nervous system—Creutzfeldt-Jakob disease	0.0138	0.0181	CbGeAlD
Doxorubicin—CBR3—cerebellum—Creutzfeldt-Jakob disease	0.0135	0.0177	CbGeAlD
Doxorubicin—AKR1A1—spinal cord—Creutzfeldt-Jakob disease	0.0131	0.0172	CbGeAlD
Doxorubicin—AURKA—lymphoid tissue—Creutzfeldt-Jakob disease	0.0122	0.016	CbGeAlD
Doxorubicin—NDUFS7—spinal cord—Creutzfeldt-Jakob disease	0.0119	0.0156	CbGeAlD
Doxorubicin—ABCB8—brain—Creutzfeldt-Jakob disease	0.0114	0.0149	CbGeAlD
Doxorubicin—CBR3—brain—Creutzfeldt-Jakob disease	0.0109	0.0143	CbGeAlD
Doxorubicin—NDUFS2—lymphoid tissue—Creutzfeldt-Jakob disease	0.0109	0.0143	CbGeAlD
Doxorubicin—YWHAG—p38 signaling mediated by MAPKAP kinases—YWHAZ—Creutzfeldt-Jakob disease	0.0108	0.0456	CbGpPWpGaD
Doxorubicin—NDUFS3—lymphoid tissue—Creutzfeldt-Jakob disease	0.0108	0.0141	CbGeAlD
Doxorubicin—AKR1A1—central nervous system—Creutzfeldt-Jakob disease	0.0106	0.014	CbGeAlD
Doxorubicin—AKR1A1—cerebellum—Creutzfeldt-Jakob disease	0.0104	0.0136	CbGeAlD
Doxorubicin—DHCR7—lymphoid tissue—Creutzfeldt-Jakob disease	0.0102	0.0134	CbGeAlD
Doxorubicin—NOS1—spinal cord—Creutzfeldt-Jakob disease	0.00994	0.013	CbGeAlD
Doxorubicin—NDUFS2—spinal cord—Creutzfeldt-Jakob disease	0.00988	0.013	CbGeAlD
Doxorubicin—NDUFS3—spinal cord—Creutzfeldt-Jakob disease	0.00976	0.0128	CbGeAlD
Doxorubicin—NDUFS7—central nervous system—Creutzfeldt-Jakob disease	0.00967	0.0127	CbGeAlD
Doxorubicin—YWHAG—LKB1 signaling events—CTSD—Creutzfeldt-Jakob disease	0.00965	0.0407	CbGpPWpGaD
Doxorubicin—NDUFS7—cerebellum—Creutzfeldt-Jakob disease	0.00945	0.0124	CbGeAlD
Doxorubicin—YWHAG—Activation of BH3-only proteins—YWHAZ—Creutzfeldt-Jakob disease	0.00942	0.0397	CbGpPWpGaD
Doxorubicin—YWHAG—lymphoid tissue—Creutzfeldt-Jakob disease	0.00938	0.0123	CbGeAlD
Doxorubicin—DHCR7—spinal cord—Creutzfeldt-Jakob disease	0.00927	0.0122	CbGeAlD
Doxorubicin—AURKA—central nervous system—Creutzfeldt-Jakob disease	0.00899	0.0118	CbGeAlD
Doxorubicin—YWHAG—IL3-mediated signaling events—YWHAZ—Creutzfeldt-Jakob disease	0.00886	0.0373	CbGpPWpGaD
Doxorubicin—YWHAG—spinal cord—Creutzfeldt-Jakob disease	0.00851	0.0112	CbGeAlD
Doxorubicin—AKR1A1—brain—Creutzfeldt-Jakob disease	0.00845	0.0111	CbGeAlD
Doxorubicin—YWHAG—Insulin-mediated glucose transport—YWHAZ—Creutzfeldt-Jakob disease	0.00837	0.0352	CbGpPWpGaD
Doxorubicin—NOS3—lymphoid tissue—Creutzfeldt-Jakob disease	0.00834	0.0109	CbGeAlD
Doxorubicin—NOS1—central nervous system—Creutzfeldt-Jakob disease	0.00807	0.0106	CbGeAlD
Doxorubicin—NDUFS2—central nervous system—Creutzfeldt-Jakob disease	0.00801	0.0105	CbGeAlD
Doxorubicin—NDUFS3—central nervous system—Creutzfeldt-Jakob disease	0.00792	0.0104	CbGeAlD
Doxorubicin—CBR1—lymphoid tissue—Creutzfeldt-Jakob disease	0.00791	0.0104	CbGeAlD
Doxorubicin—NOS1—cerebellum—Creutzfeldt-Jakob disease	0.00788	0.0103	CbGeAlD
Doxorubicin—CYP2B6—blood plasma—Creutzfeldt-Jakob disease	0.00786	0.0103	CbGeAlD
Doxorubicin—NDUFS2—cerebellum—Creutzfeldt-Jakob disease	0.00783	0.0103	CbGeAlD
Doxorubicin—NDUFS3—cerebellum—Creutzfeldt-Jakob disease	0.00774	0.0101	CbGeAlD
Doxorubicin—RALBP1—spinal cord—Creutzfeldt-Jakob disease	0.00768	0.0101	CbGeAlD
Doxorubicin—NDUFS7—brain—Creutzfeldt-Jakob disease	0.00768	0.0101	CbGeAlD
Doxorubicin—DHCR7—central nervous system—Creutzfeldt-Jakob disease	0.00752	0.00986	CbGeAlD
Doxorubicin—DHCR7—cerebellum—Creutzfeldt-Jakob disease	0.00735	0.00964	CbGeAlD
Doxorubicin—YWHAG—Class I PI3K signaling events mediated by Akt—YWHAZ—Creutzfeldt-Jakob disease	0.0072	0.0303	CbGpPWpGaD
Doxorubicin—CBR1—spinal cord—Creutzfeldt-Jakob disease	0.00717	0.00941	CbGeAlD
Doxorubicin—AURKA—brain—Creutzfeldt-Jakob disease	0.00714	0.00936	CbGeAlD
Doxorubicin—AKR1C3—spinal cord—Creutzfeldt-Jakob disease	0.00708	0.00929	CbGeAlD
Doxorubicin—YWHAG—Trk receptor signaling mediated by PI3K and PLC-gamma—YWHAZ—Creutzfeldt-Jakob disease	0.00704	0.0296	CbGpPWpGaD
Doxorubicin—YWHAG—central nervous system—Creutzfeldt-Jakob disease	0.0069	0.00905	CbGeAlD
Doxorubicin—YWHAG—cerebellum—Creutzfeldt-Jakob disease	0.00675	0.00885	CbGeAlD
Doxorubicin—YWHAG—Intrinsic Pathway for Apoptosis—YWHAZ—Creutzfeldt-Jakob disease	0.00674	0.0284	CbGpPWpGaD
Doxorubicin—DHCR7—Metabolism of lipids and lipoproteins—MTMR7—Creutzfeldt-Jakob disease	0.00657	0.0277	CbGpPWpGaD
Doxorubicin—POR—spinal cord—Creutzfeldt-Jakob disease	0.00647	0.00848	CbGeAlD
Doxorubicin—NOS1—brain—Creutzfeldt-Jakob disease	0.0064	0.0084	CbGeAlD
Doxorubicin—NDUFS2—brain—Creutzfeldt-Jakob disease	0.00636	0.00834	CbGeAlD
Doxorubicin—NDUFS3—brain—Creutzfeldt-Jakob disease	0.00628	0.00824	CbGeAlD
Doxorubicin—RALBP1—central nervous system—Creutzfeldt-Jakob disease	0.00623	0.00817	CbGeAlD
Doxorubicin—NOS3—central nervous system—Creutzfeldt-Jakob disease	0.00613	0.00804	CbGeAlD
Doxorubicin—CBR1—Metabolism of lipids and lipoproteins—MTMR7—Creutzfeldt-Jakob disease	0.00612	0.0258	CbGpPWpGaD
Doxorubicin—YWHAG—LKB1 signaling events—YWHAZ—Creutzfeldt-Jakob disease	0.00611	0.0257	CbGpPWpGaD
Doxorubicin—RALBP1—cerebellum—Creutzfeldt-Jakob disease	0.00609	0.00799	CbGeAlD
Doxorubicin—DHCR7—brain—Creutzfeldt-Jakob disease	0.00597	0.00783	CbGeAlD
Doxorubicin—CYP3A4—blood plasma—Creutzfeldt-Jakob disease	0.00593	0.00778	CbGeAlD
Doxorubicin—YWHAG—a6b1 and a6b4 Integrin signaling—YWHAZ—Creutzfeldt-Jakob disease	0.00589	0.0248	CbGpPWpGaD
Doxorubicin—CYP2D6—blood plasma—Creutzfeldt-Jakob disease	0.00584	0.00765	CbGeAlD
Doxorubicin—CBR1—central nervous system—Creutzfeldt-Jakob disease	0.00582	0.00763	CbGeAlD
Doxorubicin—NQO1—spinal cord—Creutzfeldt-Jakob disease	0.00575	0.00754	CbGeAlD
Doxorubicin—CBR1—cerebellum—Creutzfeldt-Jakob disease	0.00569	0.00746	CbGeAlD
Doxorubicin—ABCC10—lymphoid tissue—Creutzfeldt-Jakob disease	0.00566	0.00742	CbGeAlD
Doxorubicin—AKR1C3—cerebellum—Creutzfeldt-Jakob disease	0.00562	0.00737	CbGeAlD
Doxorubicin—YWHAG—FoxO family signaling—YWHAZ—Creutzfeldt-Jakob disease	0.0055	0.0232	CbGpPWpGaD
Doxorubicin—YWHAG—brain—Creutzfeldt-Jakob disease	0.00548	0.00719	CbGeAlD
Doxorubicin—ABCC10—spinal cord—Creutzfeldt-Jakob disease	0.00513	0.00673	CbGeAlD
Doxorubicin—POR—cerebellum—Creutzfeldt-Jakob disease	0.00513	0.00673	CbGeAlD
Doxorubicin—YWHAG—Role of Calcineurin-dependent NFAT signaling in lymphocytes—YWHAZ—Creutzfeldt-Jakob disease	0.00509	0.0214	CbGpPWpGaD
Doxorubicin—RALBP1—brain—Creutzfeldt-Jakob disease	0.00495	0.00649	CbGeAlD
Doxorubicin—NOS3—brain—Creutzfeldt-Jakob disease	0.00487	0.00638	CbGeAlD
Doxorubicin—NOS2—Circadian rythm related genes—NPAS2—Creutzfeldt-Jakob disease	0.00477	0.0201	CbGpPWpGaD
Doxorubicin—NQO1—central nervous system—Creutzfeldt-Jakob disease	0.00466	0.00611	CbGeAlD
Doxorubicin—CBR1—brain—Creutzfeldt-Jakob disease	0.00462	0.00606	CbGeAlD
Doxorubicin—YWHAG—Translocation of GLUT4 to the plasma membrane—YWHAZ—Creutzfeldt-Jakob disease	0.00462	0.0194	CbGpPWpGaD
Doxorubicin—AKR1C3—brain—Creutzfeldt-Jakob disease	0.00456	0.00598	CbGeAlD
Doxorubicin—NQO1—cerebellum—Creutzfeldt-Jakob disease	0.00456	0.00598	CbGeAlD
Doxorubicin—CYP1B1—lymphoid tissue—Creutzfeldt-Jakob disease	0.00445	0.00584	CbGeAlD
Doxorubicin—YWHAG—mTOR signaling pathway—YWHAZ—Creutzfeldt-Jakob disease	0.00433	0.0183	CbGpPWpGaD
Doxorubicin—ABCB1—blood plasma—Creutzfeldt-Jakob disease	0.0042	0.00551	CbGeAlD
Doxorubicin—ABCC3—central nervous system—Creutzfeldt-Jakob disease	0.00418	0.00549	CbGeAlD
Doxorubicin—POR—brain—Creutzfeldt-Jakob disease	0.00417	0.00546	CbGeAlD
Doxorubicin—ABCC10—cerebellum—Creutzfeldt-Jakob disease	0.00407	0.00534	CbGeAlD
Doxorubicin—YWHAG—Regulation of nuclear beta catenin signaling and target gene transcription—YWHAZ—Creutzfeldt-Jakob disease	0.00372	0.0157	CbGpPWpGaD
Doxorubicin—NQO1—brain—Creutzfeldt-Jakob disease	0.0037	0.00485	CbGeAlD
Doxorubicin—NDUFS7—Metabolism—MTMR7—Creutzfeldt-Jakob disease	0.00366	0.0154	CbGpPWpGaD
Doxorubicin—NDUFS3—Metabolism—MTMR7—Creutzfeldt-Jakob disease	0.00366	0.0154	CbGpPWpGaD
Doxorubicin—DHCR7—Metabolism of lipids and lipoproteins—NPAS2—Creutzfeldt-Jakob disease	0.00363	0.0153	CbGpPWpGaD
Doxorubicin—AKR1C3—Metabolism of lipids and lipoproteins—MTMR7—Creutzfeldt-Jakob disease	0.00345	0.0145	CbGpPWpGaD
Doxorubicin—NDUFS2—Metabolism—MTMR7—Creutzfeldt-Jakob disease	0.00344	0.0145	CbGpPWpGaD
Doxorubicin—CBR1—Metabolism of lipids and lipoproteins—NPAS2—Creutzfeldt-Jakob disease	0.00339	0.0143	CbGpPWpGaD
Doxorubicin—ABCC3—brain—Creutzfeldt-Jakob disease	0.00332	0.00436	CbGeAlD
Doxorubicin—CYP2D6—brainstem—Creutzfeldt-Jakob disease	0.00331	0.00434	CbGeAlD
Doxorubicin—ABCC10—brain—Creutzfeldt-Jakob disease	0.00331	0.00433	CbGeAlD
Doxorubicin—CYP1B1—central nervous system—Creutzfeldt-Jakob disease	0.00327	0.00429	CbGeAlD
Doxorubicin—TOP2A—Circadian rythm related genes—NPAS2—Creutzfeldt-Jakob disease	0.00326	0.0137	CbGpPWpGaD
Doxorubicin—CYP1B1—cerebellum—Creutzfeldt-Jakob disease	0.0032	0.0042	CbGeAlD
Doxorubicin—YWHAG—Cell Cycle—YWHAZ—Creutzfeldt-Jakob disease	0.00306	0.0129	CbGpPWpGaD
Doxorubicin—CYP2B6—lymphoid tissue—Creutzfeldt-Jakob disease	0.00306	0.00401	CbGeAlD
Doxorubicin—ABCG2—spinal cord—Creutzfeldt-Jakob disease	0.00301	0.00394	CbGeAlD
Doxorubicin—YWHAG—ErbB1 downstream signaling—YWHAZ—Creutzfeldt-Jakob disease	0.00299	0.0126	CbGpPWpGaD
Doxorubicin—NOS1—Myometrial Relaxation and Contraction Pathways—YWHAZ—Creutzfeldt-Jakob disease	0.00297	0.0125	CbGpPWpGaD
Doxorubicin—DHCR7—Metabolism—MTMR7—Creutzfeldt-Jakob disease	0.00292	0.0123	CbGpPWpGaD
Doxorubicin—ABCC1—cerebellum—Creutzfeldt-Jakob disease	0.00288	0.00377	CbGeAlD
Doxorubicin—CBR1—Metabolism—MTMR7—Creutzfeldt-Jakob disease	0.00273	0.0115	CbGpPWpGaD
Doxorubicin—YWHAG—PDGFR-beta signaling pathway—YWHAZ—Creutzfeldt-Jakob disease	0.0026	0.011	CbGpPWpGaD
Doxorubicin—CYP1B1—brain—Creutzfeldt-Jakob disease	0.0026	0.00341	CbGeAlD
Doxorubicin—ABCG2—cerebellum—Creutzfeldt-Jakob disease	0.00238	0.00312	CbGeAlD
Doxorubicin—ABCB11—Metabolism of lipids and lipoproteins—MTMR7—Creutzfeldt-Jakob disease	0.00236	0.00996	CbGpPWpGaD
Doxorubicin—ABCC1—brain—Creutzfeldt-Jakob disease	0.00234	0.00307	CbGeAlD
Doxorubicin—ABCC3—Metabolism of lipids and lipoproteins—MTMR7—Creutzfeldt-Jakob disease	0.00227	0.00955	CbGpPWpGaD
Doxorubicin—YWHAG—Calcium Regulation in the Cardiac Cell—YWHAZ—Creutzfeldt-Jakob disease	0.00226	0.00952	CbGpPWpGaD
Doxorubicin—CYP2B6—central nervous system—Creutzfeldt-Jakob disease	0.00225	0.00295	CbGeAlD
Doxorubicin—YWHAG—Apoptosis—YWHAZ—Creutzfeldt-Jakob disease	0.00219	0.00922	CbGpPWpGaD
Doxorubicin—YWHAG—Myometrial Relaxation and Contraction Pathways—YWHAZ—Creutzfeldt-Jakob disease	0.00219	0.00922	CbGpPWpGaD
Doxorubicin—YWHAG—SIDS Susceptibility Pathways—YWHAZ—Creutzfeldt-Jakob disease	0.00218	0.00917	CbGpPWpGaD
Doxorubicin—NDUFS7—Metabolism—NPAS2—Creutzfeldt-Jakob disease	0.00202	0.00852	CbGpPWpGaD
Doxorubicin—NDUFS3—Metabolism—NPAS2—Creutzfeldt-Jakob disease	0.00202	0.00852	CbGpPWpGaD
Doxorubicin—ABCG2—brain—Creutzfeldt-Jakob disease	0.00194	0.00254	CbGeAlD
Doxorubicin—AKR1C3—Metabolism of lipids and lipoproteins—NPAS2—Creutzfeldt-Jakob disease	0.00191	0.00803	CbGpPWpGaD
Doxorubicin—NDUFS2—Metabolism—NPAS2—Creutzfeldt-Jakob disease	0.0019	0.00801	CbGpPWpGaD
Doxorubicin—YWHAG—Membrane Trafficking—YWHAZ—Creutzfeldt-Jakob disease	0.00186	0.00783	CbGpPWpGaD
Doxorubicin—CYP2B6—brain—Creutzfeldt-Jakob disease	0.00179	0.00234	CbGeAlD
Doxorubicin—ABCC1—Metabolism of lipids and lipoproteins—MTMR7—Creutzfeldt-Jakob disease	0.00178	0.00748	CbGpPWpGaD
Doxorubicin—NOS3—Myometrial Relaxation and Contraction Pathways—YWHAZ—Creutzfeldt-Jakob disease	0.00174	0.00732	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism of lipids and lipoproteins—MTMR7—Creutzfeldt-Jakob disease	0.00172	0.00724	CbGpPWpGaD
Doxorubicin—CYP3A4—central nervous system—Creutzfeldt-Jakob disease	0.0017	0.00223	CbGeAlD
Doxorubicin—CYP2D6—central nervous system—Creutzfeldt-Jakob disease	0.00167	0.00219	CbGeAlD
Doxorubicin—ABCB1—lymphoid tissue—Creutzfeldt-Jakob disease	0.00163	0.00214	CbGeAlD
Doxorubicin—CYP2D6—cerebellum—Creutzfeldt-Jakob disease	0.00163	0.00214	CbGeAlD
Doxorubicin—DHCR7—Metabolism—NPAS2—Creutzfeldt-Jakob disease	0.00162	0.00681	CbGpPWpGaD
Doxorubicin—NQO1—Metabolism—MTMR7—Creutzfeldt-Jakob disease	0.00159	0.00671	CbGpPWpGaD
Doxorubicin—AKR1C3—Metabolism—MTMR7—Creutzfeldt-Jakob disease	0.00154	0.00647	CbGpPWpGaD
Doxorubicin—CBR1—Metabolism—NPAS2—Creutzfeldt-Jakob disease	0.00151	0.00635	CbGpPWpGaD
Doxorubicin—ABCB1—spinal cord—Creutzfeldt-Jakob disease	0.00148	0.00194	CbGeAlD
Doxorubicin—XDH—Metabolism—MTMR7—Creutzfeldt-Jakob disease	0.00143	0.00602	CbGpPWpGaD
Doxorubicin—CYP2D6—brain—Creutzfeldt-Jakob disease	0.00133	0.00174	CbGeAlD
Doxorubicin—ABCB11—Metabolism of lipids and lipoproteins—NPAS2—Creutzfeldt-Jakob disease	0.00131	0.00551	CbGpPWpGaD
Doxorubicin—NOS3—Metabolism—MTMR7—Creutzfeldt-Jakob disease	0.0013	0.00547	CbGpPWpGaD
Doxorubicin—ABCC3—Metabolism of lipids and lipoproteins—NPAS2—Creutzfeldt-Jakob disease	0.00125	0.00528	CbGpPWpGaD
Doxorubicin—ABCB1—central nervous system—Creutzfeldt-Jakob disease	0.0012	0.00158	CbGeAlD
Doxorubicin—ABCB1—cerebellum—Creutzfeldt-Jakob disease	0.00118	0.00154	CbGeAlD
Doxorubicin—NOS1—Hemostasis—YWHAZ—Creutzfeldt-Jakob disease	0.00115	0.00485	CbGpPWpGaD
Doxorubicin—ABCB11—Metabolism—MTMR7—Creutzfeldt-Jakob disease	0.00105	0.00443	CbGpPWpGaD
Doxorubicin—ABCC3—Metabolism—MTMR7—Creutzfeldt-Jakob disease	0.00101	0.00425	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism of lipids and lipoproteins—NPAS2—Creutzfeldt-Jakob disease	0.000982	0.00414	CbGpPWpGaD
Doxorubicin—ABCB1—Allograft Rejection—HLA-DQB1—Creutzfeldt-Jakob disease	0.000974	0.0041	CbGpPWpGaD
Doxorubicin—ABCB1—brain—Creutzfeldt-Jakob disease	0.000954	0.00125	CbGeAlD
Doxorubicin—CYP1B1—Metabolism of lipids and lipoproteins—NPAS2—Creutzfeldt-Jakob disease	0.00095	0.004	CbGpPWpGaD
Doxorubicin—NQO1—Metabolism—NPAS2—Creutzfeldt-Jakob disease	0.00088	0.00371	CbGpPWpGaD
Doxorubicin—NOS2—Hemostasis—YWHAZ—Creutzfeldt-Jakob disease	0.000869	0.00366	CbGpPWpGaD
Doxorubicin—AKR1C3—Metabolism—NPAS2—Creutzfeldt-Jakob disease	0.000849	0.00358	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism—MTMR7—Creutzfeldt-Jakob disease	0.000791	0.00333	CbGpPWpGaD
Doxorubicin—XDH—Metabolism—NPAS2—Creutzfeldt-Jakob disease	0.00079	0.00333	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism—MTMR7—Creutzfeldt-Jakob disease	0.000765	0.00322	CbGpPWpGaD
Doxorubicin—NOS3—Metabolism—NPAS2—Creutzfeldt-Jakob disease	0.000718	0.00302	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—MTMR7—Creutzfeldt-Jakob disease	0.000696	0.00293	CbGpPWpGaD
Doxorubicin—NOS3—Hemostasis—YWHAZ—Creutzfeldt-Jakob disease	0.000675	0.00284	CbGpPWpGaD
Doxorubicin—ABCB11—Metabolism—NPAS2—Creutzfeldt-Jakob disease	0.000582	0.00245	CbGpPWpGaD
Doxorubicin—ABCC3—Metabolism—NPAS2—Creutzfeldt-Jakob disease	0.000558	0.00235	CbGpPWpGaD
Doxorubicin—NOS1—Disease—YWHAZ—Creutzfeldt-Jakob disease	0.000558	0.00235	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—MTMR7—Creutzfeldt-Jakob disease	0.00051	0.00215	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—YWHAZ—Creutzfeldt-Jakob disease	0.000489	0.00206	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism—NPAS2—Creutzfeldt-Jakob disease	0.000437	0.00184	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism—NPAS2—Creutzfeldt-Jakob disease	0.000423	0.00178	CbGpPWpGaD
Doxorubicin—NOS2—Disease—YWHAZ—Creutzfeldt-Jakob disease	0.000421	0.00177	CbGpPWpGaD
Doxorubicin—AKR1C3—Disease—YWHAZ—Creutzfeldt-Jakob disease	0.000387	0.00163	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—NPAS2—Creutzfeldt-Jakob disease	0.000385	0.00162	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—MTMR7—Creutzfeldt-Jakob disease	0.000376	0.00158	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—MTMR7—Creutzfeldt-Jakob disease	0.000355	0.00149	CbGpPWpGaD
Doxorubicin—NOS3—Disease—YWHAZ—Creutzfeldt-Jakob disease	0.000327	0.00138	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—NPAS2—Creutzfeldt-Jakob disease	0.000282	0.00119	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—YWHAZ—Creutzfeldt-Jakob disease	0.000271	0.00114	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—MTMR7—Creutzfeldt-Jakob disease	0.000232	0.000976	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—YWHAZ—Creutzfeldt-Jakob disease	0.000229	0.000964	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—NPAS2—Creutzfeldt-Jakob disease	0.000208	0.000876	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—YWHAZ—Creutzfeldt-Jakob disease	0.000199	0.000839	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—NPAS2—Creutzfeldt-Jakob disease	0.000196	0.000826	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—NPAS2—Creutzfeldt-Jakob disease	0.000128	0.00054	CbGpPWpGaD
